| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 10,693 | 9,641 | 19,661 | | Selling General and Administrative | 2,991 | 3,738 | 6,558 | | Non Recurring |
-
|
-
| 8,471 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (13,684) | (13,379) | (34,690) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,082 | 3,278 | 3,883 | | Earnings Before Interest And Taxes | (11,602) | (10,101) | (30,807) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (11,602) | (10,101) | (30,807) | | Income Tax Expense | (363) |
-
| 1,106 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,239) | (10,101) | (31,913) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,239) | (10,101) | (31,913) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,239) | ($10,101) | ($31,913) |
|
0.10% Nasdaq 
0.0392 (6.31%) 
Income Statement
